Stocksigma LogoStocksigma Logo

Paras Healthcare Reports Robust Q2 & H1 FY27 Results Post Successful Listing

Paras Healthcare, listed on 28th Oct'26, reported strong Q2 FY27 revenue growth of 22.8% YoY to ₹510.9 Cr, with operating EBITDA rising 47.0% YoY to ₹120.2

Paras Healthcare Reports Robust Q2 & H1 FY27 Results Post Successful Listing

Paras Healthcare Limited · Investor Presentation · 06 Nov 2026, 6:16 pm

Paras Healthcare Reports Robust Q2 & H1 FY27 Results Post Successful Listing Paras Healthcare, listed on 28th Oct'26, reported strong Q2 FY27 revenue growth of 22.8% YoY to ₹510.9 Cr, with operating EBITDA rising 47.0% YoY to ₹120.2 Cr (margin up 390 bps to 23.5%) and PAT surging 3.3x YoY to ₹40.4 Cr. For H1 FY27, revenue reached ₹981.2 Cr (+25.1% YoY) and PAT surged 7.9x to ₹90.0 Cr. Operational bed occupancy improved to 73.0% (vs 59.0% in H1 FY26) alongside ARPOB of ₹48.9k. IPO proceeds reduced pro-forma net debt to ₹143.0 Cr (0.15x net debt/equity).

Original exchange filing (PDF)

More announcements from Paras Healthcare Limited

All Paras Healthcare Limited announcements